Study Finds Viagra and Cialis Do Not Reduce Alzheimer’s, Dementia Risk

October 5, 2022 by TWN Staff
Study Finds Viagra and Cialis Do Not Reduce Alzheimer’s, Dementia Risk
(Photo by charles deluvio via UnSplash)

WASHINGTON — Despite the results of a previous study, sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for treating dementia, according to the National Institutes of Health.

The institute recently delved into the situation with its Drug Repurposing for Effective Alzheimer’s Medicines study.

In the new study, NIH researchers and collaborators used data from Medicare beneficiaries and determined the medications sildenafil and tadalafil do not reduce the risk of Alzheimer’s disease and related dementias.

The study was funded by the NIH National Institute on Aging and results published in Brain Communications.

The NIA scientific team tested a class of drugs called phosphodiesterase-5 inhibitors. PDE5 inhibitors, of which sildenafil and tadalafil are examples, work by relaxing smooth muscle cells.

Sildenafil and tadalafil are U.S. Food and Drug Administration-approved treatments for erectile dysfunction and pulmonary atrial hypertension, a type of high blood pressure that affects the arteries in the lungs and the right side of the heart.

The scientists examined the risk of Alzheimer’s and related dementias using two groups of Medicare beneficiaries with PAH, those who were being treated with sildenafil or tadalafil, and those treated with another class of drugs.

They also tested whether sildenafil had effects on cell culture-based models of Alzheimer’s.

Results showed no reduced risk of Alzheimer’s and related dementias in patients treated with PDE5 inhibitors and no evidence that PDE5 inhibitors corrected molecular abnormalities associated with Alzheimer’s.

A+
a-
  • Alzheimer's disease
  • Cialis
  • dementia
  • drug repurposing
  • National Institutes of Health
  • Viagra
  • In The News

    Health

    Voting

    Health

    New Trump Vaccine Policy Limits Access to COVID Shots

    WASHINGTON (AP) — The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending... Read More

    WASHINGTON (AP) — The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some people who want a vaccine this fall will be able to get one. Top officials... Read More

    Choose Wisely: Medicaid Cuts Could Cripple Trump’s America First Agenda

    In Washington, D.C., there is one rule you can count on: nothing is ever as it seems. The mirage of... Read More

    In Washington, D.C., there is one rule you can count on: nothing is ever as it seems. The mirage of smoke and mirrors provides the ambiance, but not the needed reflection. The current debate over cutting Medicaid is no different. It’s not just a budget fight... Read More

    After US Cuts Funding, WHO Chief Defends $2.1B Budget Request by Comparing It With Cost of War

    GENEVA (AP) — Stripped of U.S. funding, the World Health Organization chief on Monday appealed to member countries to support its “extremely... Read More

    GENEVA (AP) — Stripped of U.S. funding, the World Health Organization chief on Monday appealed to member countries to support its “extremely modest” request for a $2.1 billion annual budget by putting that sum into perspective next to outlays for ad campaigns for tobacco or the cost of... Read More

    May 19, 2025
    by Jesse Zucker
    Fitness and Nutrition Guide to GLP-1s

    WASHINGTON — Many people face challenges when trying to maintain a healthy weight. Over the last few years, GLP-1 medications,... Read More

    WASHINGTON — Many people face challenges when trying to maintain a healthy weight. Over the last few years, GLP-1 medications, originally intended for type 2 diabetes, have shown promising results in helping with weight loss. However, weight alone isn’t the whole story when it comes to... Read More

    May 19, 2025
    by Jesse Zucker
    When It Comes to Sleep, Quality Matters

    WASHINGTON — Do you ever feel like your brain slows down the day after a bad night’s sleep? It’s not... Read More

    WASHINGTON — Do you ever feel like your brain slows down the day after a bad night’s sleep? It’s not just your imagination. A new review suggests how sleep quality early in life may influence brain development and cognitive performance in school. Here, we will take... Read More

    Reform Supplemental Oxygen for Chronically Ill Patients

    For the 1.5 million Americans living with chronic lung and heart disease and other respiratory conditions, supplemental oxygen is not... Read More

    For the 1.5 million Americans living with chronic lung and heart disease and other respiratory conditions, supplemental oxygen is not a luxury or something that would be nice to have — it is a literal lifeline. Supplemental oxygen allows patients to live more active, independent lives... Read More

    News From The Well
    scroll top